Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved tags : Fda approval save search
PERRIGO ANNOUNCES U.S. FDA APPROVAL FOR OTC USE OF NASONEX® 24HR ALLERGY
Published: 2022-03-17 (Crawled : 21:00) - prnewswire.com
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
|
| O: -1.17%
H: 1.6%
C: 0.47%
nasonex fda fda approval approval one
RINVOQ® (upadacitinib) Receives FDA Approval for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
Published: 2022-03-16 (Crawled : 22:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.72%
H: 0.92%
C: 0.9%
rinvoq treatment fda fda approval approval active ulcerative colitis
KemPharm Earns $1.975 Million Fee from Corium Following FDA Approval of the Corium Product ADLARITY® (donepezil transdermal system)
Published: 2022-03-16 (Crawled : 12:00) - globenewswire.com
KMPH | $5.46 6.04% 0
|
Manufacturing
|
| O: 1.37%
H: 3.47%
C: 1.93%
adlarity fda fda approval derm approval system one transdermal system
Viatris Inc. Announces Receipt of the First FDA Approval for Generic Version of Symbicort® Inhalation Aerosol, Breyna™ (Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol), in Partnership with Kindeva
Published: 2022-03-16 (Crawled : 12:00) - prnewswire.com
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 1.46%
H: 3.86%
C: 2.82%
symbicort fda partnership fda approval approval
Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer
Published: 2022-03-12 (Crawled : 00:20) - globenewswire.com
MYGN F | $18.51 -0.7% -0.7% 640K
|
Health Technology
| Email alert
Add to watchlist
bracanalysis diagnostic fda genetic lynparza fda approval approval cancer breast cancer
TRACON Pharmaceuticals Announces FDA Approval of Amended ENVASARC Protocol
Published: 2022-03-10 (Crawled : 14:00) - globenewswire.com
TCON | $2.13 -6.99% -7.51% 350K
|
Health Technology
|
| O: 6.1%
H: 0.0%
C: 0.0%
fda als fda approval approval
ADMA BioCenters Receives FDA Approval for its Fifth Plasma Collection Center, Located in Conyers, GA
Published: 2022-03-07 (Crawled : 22:00) - admabiologics.com
ADMA 4 | $6.21 2.82% 2.74% 3M
|
Health Technology
|
| O: 0.0%
H: 3.59%
C: 1.8%
fda fda approval approval
CARVYKTI™ (ciltacabtagene autoleucel), BCMA-Directed CAR-T Therapy, Receives U.S. FDA Approval for the Treatment of Adult Patients With Relapsed or Refractory Multiple Myeloma
Published: 2022-03-01 (Crawled : 09:00) - biospace.com/
LEGN | $47.16 -3.42% -3.54% 820K
|
Health Technology
|
| O: 4.59%
H: 0.0%
C: -7.26%
treatment fda fda approval car-t approval cel therapy
Lantheus Receives U.S. FDA Approval of New Manufacturing Facility
Published: 2022-02-23 (Crawled : 13:00) - globenewswire.com
LNTH | News | $62.34 1.4% 1.38% 1.3M
|
Health Technology
|
| O: 1.17%
H: 2.85%
C: -1.47%
fda fda approval approval
Theragnostics Announces US FDA Approval for its Radiodiagnostic Imaging Drug NephroScan™ (Kit for the Preparation of Technetium Tc 99m Succimer Injection)
Published: 2022-02-23 (Crawled : 09:00) - prnewswire.com
GE | $152.94 -1.75% 0.0% 6M
|
Electronic Technology
|
| O: -0.38%
H: 1.14%
C: -1.22%
diagnostic fda ces fda approval drug imaging approval injection scan
Medtronic receives FDA approval for InterStim X™ system, the next generation of the most personalized sacral nerve stimulation therapy for bladder and bowel control
Published: 2022-02-22 (Crawled : 20:00) - prnewswire.com
MDT | $79.19 0.14% 0.0% 6.1M
|
Health Technology
|
| O: 0.5%
H: 0.25%
C: -1.16%
fda control fda approval approval system therapy bladder
Abbott's CardioMEMS™ HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart Failure
Published: 2022-02-21 (Crawled : 15:00) - biospace.com/
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
| Email alert
Add to watchlist
fda heart fda approval cardio approval system
Agios Announces FDA Approval of PYRUKYND® (mitapivat) as First Disease-Modifying Therapy for Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency
Published: 2022-02-17 (Crawled : 21:00) - globenewswire.com
AGIO | News | $29.43 1.38% 1.36% 550K
|
Health Technology
|
| O: 1.09%
H: 2.01%
C: -1.21%
pyrukynd fda fda approval anemia approval disease therapy
ASCENSIA DIABETES CARE ANNOUNCES FDA APPROVAL OF THE EVERSENSE E3 CONTINUOUS GLUCOSE MONITORING SYSTEM FOR USE FOR UP TO 6 MONTHS
Published: 2022-02-14 (Crawled : 12:30) - prnewswire.com
SENS | $0.416 3.43% 0.7% 2.2M
|
Electronic Technology
|
| O: -28.66%
H: 2.62%
C: -7.86%
fda fda approval approval system diabetes eversense
Senseonics Announces FDA Approval of the Eversense® E3 Continuous Glucose Monitoring System for Use for Up to 6 months; Provides 2022 Business Outlook
Published: 2022-02-11 (Crawled : 15:00) - biospace.com/
SENS | $0.416 3.43% 0.7% 2.2M
|
Electronic Technology
|
| O: -12.05%
H: 0.0%
C: 0.0%
eversense fda ces fda approval approval system
Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan
Published: 2022-02-07 (Crawled : 13:30) - ir.check-cap.com
CHEK | $2.26 3.67% 3.54% 43K
|
Health Technology
|
| O: 11.82%
H: 9.8%
C: 5.1%
fda application fda approval approval scan
Viatris is First to Receive FDA Approval of Generic Restasis® (Cyclosporine Ophthalmic Emulsion 0.05%) to Treat Dry Eye Disease
Published: 2022-02-03 (Crawled : 23:00) - prnewswire.com
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -2.48%
H: 0.0%
C: 0.0%
restasis dry eye fda eye fda approval eye disease approval disease ophthalmic emulsion
ViiV Healthcare Announces US FDA Approval of Cabenuva (cabotegravir, rilpivirine) for Use Every Two Months, Expanding the Label of the First and Only Complete Long-Acting HIV Treatment
Published: 2022-02-01 (Crawled : 14:30) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.09%
H: 0.8%
C: 0.63%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.45%
H: 0.53%
C: 0.42%
treatment fda health fda approval thc approval hiv
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine Spikevax
Published: 2022-01-31 (Crawled : 18:00) - biospace.com/
MRNA S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: 0.36%
H: 6.42%
C: 5.8%
covid-19 fda fda approval approval covid vaccine
Immunocore announces FDA approval of KIMMTRAK® (tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma
Published: 2022-01-26 (Crawled : 13:00) - biospace.com/
IMCR | $54.765 0.34% 0.34% 430K
|
Manufacturing
|
| O: 8.85%
H: 3.44%
C: -1.21%
kimmtrak treatment fda fda approval approval
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.